FXYD5 and colorectal carcinoma: Consistent with this finding, we assessed the expression of dysadherin in CRC by comparing stage II CRC, which had not spread, and stage III CRC, which had spread to lymph nodes (Table S4 and S5), and verified the correlation between dysadherin and p-paxillin in cell migratory and invasive phenotypes 19.